Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-23T07:53:42.719Z Has data issue: false hasContentIssue false

Papel modulador del dolor de la melatonina en los trastornos de la conducta alimentaria

Published online by Cambridge University Press:  12 May 2020

H. Papezová
Affiliation:
Departamento de Psiquiatría, Primera Facultad de Medicina, Universidad Carlos de Praga, Ke Karlovu 11, 12821Praga 2, República Checa
A. Yamamotová
Affiliation:
Departamento de Fisiología Normal, Patológica y Clínica, Tercera Facultad de Medicina, Universidad Carlos de Praga, Praga, República Checa
J. Nedvíková
Affiliation:
lnstituto de Endocrinología, Praga, República Checa
Get access

Resumen

El objetivo de este estudio era examinar el efecto de la melatonina sobre el umbral al dolor térmico en pacientes femeninos con trastornos de la conducta alimentaria. Se incluyó en el estudio a catorce pacientes. Encontramos una relación parabólica entre el umbral al dolor y el contenido de sulfatoximelatonina de la orina (r = 0,6299, P < 0,05). Podemos especular que el aumento en la gravedad del trastorno de la conducta alimentaria puede disminuir tanto el nivel de melatonina como la sensibilidad al dolor. Por contraste con el efecto analgésico esperado de la melatonina, nuestros resultados mostraron su posible influencia normalizadora también sobre la sensibilidad al dolor disminuida patológicamente.

Type
Comunicación breve

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bibliografía

Beam, J, Treasure, J, Murphy, M, Franey, C, Arencit, J, Wheeler, M, et al. A study of sulphatoxymelatonin excrec-tion and gonadotropin status during weight gain in anorexia nervosa. Br J Psychiatry 1988; 152: 372–6.Google Scholar
Benedetti, F. Cholecystokinin type A and type B receptors and their modulation of opiod analgesia. News Physiol Sci 1997; 12:263–8.Google Scholar
Brambilla, F, Fraschini, F, Esposti, G, Bossolo, PA, Marelli, G, Ferrari, E. Melatonin circadian rhythm in anorexia nervosa and obesity. Psychiatry Res 1988; 23: 267–76.CrossRefGoogle ScholarPubMed
Ebadi, M, Govitrapong, P, Phansuwan-Pujito, P, Nelson, F, Reiter, RJ. Pineal opiod receptors and analgesic action of melatotin, Pineal Res 1998; 24: 193200.CrossRefGoogle Scholar
Golombek, DA, Pévet, P, Cardinali, DP. Melatonin effects on behavior: possible mediation by central GABAergic system. Neurosci Biobehav Rev 1996; 20:403–12.CrossRefGoogle ScholarPubMed
Kennedy, SH, Brown, GM, McVey, G, Garfinkel, PE. Pineal and adrenal function before and after refeeding in anorexia nervosa. Biol Psychiatry 1991; 30: 216–24.CrossRefGoogle ScholarPubMed
Krieg, JC, Roscher, S, Strian, F, Pirke, KM, Lautenbacher, S. Pain sensitivity in recovered anorexics, restrined and unrestrained eaters. J Psychosom Res 1993; 37:359–62.CrossRefGoogle Scholar
Lariviere, WR, Melzack, R. The role of corticotropin-rela-sing factor in pain and analgesia. Pain 2000; 84: 112.CrossRefGoogle ScholarPubMed
Lautenbacher, S, Pauls, AM, Strian, F, Pirke, KM, Krieg, JC. Pain sensitivity in anorexia and bulimia nervosa. Biol Psychiatry 1991; 29: 1073–8.CrossRefGoogle ScholarPubMed
Morley, JE. Anorexia of aging: physiologic and pathologic. Am J Clin Nutr 1997; 66: 760–73.CrossRefGoogle ScholarPubMed
Mortola, JF, Laughlin, GA, Yen, SS. Melatonin rhythms in women with anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab 1993; 77:1540–4.Google ScholarPubMed
Nelson, W, Tong, YL, Lee, JK, Halberg, F. Methods for consi-norrhmometry. Chronobiologia 1979; 6: 305–23.Google Scholar
Sawynok, J, Reid, A. Interactions of descending serotonergic systems with other neurotransmitters in the modulation of nociception. Behav Brain Res 1996; 73: 63–8.CrossRefGoogle ScholarPubMed
Simón, EJ, Hiller, JM. Opioid peptides and opioid receptors. In: Siegel, GJ, Agranoff, BW, Aklbers, RW, Molínoff, PB, Eds. Basic neurochemistry: molecular, cellular, and medical aspects. New York: Raven Press; 1994. p. 321–38.Google Scholar
Silver, H, Barash, I, Odnopozov, N, Jahjah, N, Mizruhin, A. Melatonin secretion uring fluvoxamine treatment in medicated chronic schizophenic patients: evidence for the development of tolerance to selective serotonin re-uptake inhibitor. Biol Psychiatry 1996; 40:75–7.CrossRefGoogle Scholar
De, Zwaan M, Biener, D, Schneider, C, Stacher, G. Relationship between threshols to thermally and to mechanically induced pain in patients with eating disorders and health subjects. Pain 1996; 67: 511–2.Google Scholar
Tortosa, F, Puig-Domingo, M, Peinado, MA, Oriola, J, Webb, SM, de, Leiva A. Enhaced cicadian rhytthm of melatonin in anorexia nervosa. Acta Endocrinol 1989; 120:574–8.CrossRefGoogle Scholar
Waldauser, F, Steger, H. Physiology of melatonin secretion in man. In: Wagner, TOF, Fillicori, M, Eds. Episodic hormone secretion: from basic science to clinical application. Hameln (Germany): TM-Verlag; 1987. p.105–12.Google Scholar
Yamamotová, A, Papezová, H, Hájková, I. Stress-induced analgesia in patients with eating disorders depends on the type of stress. Physiological Res 1999; 48 Suppl 1: S140.Google Scholar